Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06407596
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2024-03-29
Brief Title:
HILT or Conventional Combined Physical Therapy in the Management of Hemiplegic Shoulder Pain
Sponsor:
Ankara City Hospital Bilkent
Organization:
Ankara City Hospital Bilkent
Study Overview
Official Title:
High-intensity Laser Therapy HILT or Conventional Combined Physical Therapy in the Management of Hemiplegic Shoulder Pain Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Hemiplegic shoulder pain is one of the most common complications after a stroke There are many treatment strategies for this complication High-intensity laser therapy HILT is a new treatment option and we aimed to compare the effectiveness of conventional electrotherapy agents and HILT in this study
Patients and methods Participants N 42 were randomized into the HILT n 21 and TENSUS n 21 groups Group 1 received 3 sessions of HILT per week for 3 weeks in addition to a therapeutic exercise program that performed 5 sessions per week for 3 weeks Group 2 received conventional physical therapy and a therapeutic exercise program for HSP of 5 sessions per week for 3 weeks Patients were assessed before and after treatment on the on the 6th week for radiological evaluation with ultrasonography and for clinical parameters with VAS AMAT MRS and FIQ scores
Patients and methods Participants N 42 were randomized into the HILT n 21 and TENSUS n 21 groups Group 1 received 3 sessions of HILT per week for 3 weeks in addition to a therapeutic exercise program that performed 5 sessions per week for 3 weeks Group 2 received conventional physical therapy and a therapeutic exercise program for HSP of 5 sessions per week for 3 weeks Patients were assessed before and after treatment on the on the 6th week for radiological evaluation with ultrasonography and for clinical parameters with VAS AMAT MRS and FIQ scores
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None